Zoldonrasib
RMC-9805 is a covalent, oral, and mutant-selective inhibitor targeting the active state of KRASG12D. It functions by forming a stable, high-affinity complex with KRASG12D and cyclophilin A, blocking downstream signaling. This mechanism has demonstrated induction of apoptosis and tumor regression in preclinical in vivo and in vitro models of KRASG12D-driven cancers.
Product Specifications
CAS Number
2922732-54-3
Product Name Alternative
KRAS G12D, KRAS G12D IN 18, KRAS G12D inhibitor 18, Zoldonrasib
Field of Research
Cell Biology, Pharmacology & Drug Discovery, Signal Transduction
Purity
98.10% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (4.28 mM) ; DMSO:252.5 mg/mL (216.1 mM)
Smiles
O=C1OCC (C) (C) CC=2C3=CC (=CC=C3N (C2C4=CC (=CN=C4C (OC) C) N5CCN (CC5) C6CC6) CC (F) (F) F) N7CCOC (C7) CC (NC (=O) C (N8CCC9 (CN (C (=O) C%10N (C) C%10C%11CC%11) CC9) C8) C%12CCCC%12) C (=O) N%13NC1CCC%13
Molecular Formula
C63H88F3N11O7
Molecular Weight
1168.44
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
L4500-07A 50 µg
LRP, MVP (Major Vault Protein, Lung-resistance Related Protein) discontinued, see L4500-10
Sign In for Pricing
View Details 